Masaru Hayashi

High levels of plasma brain natriuretic peptide and interleukin-6 after optimized treatment for heart failure are independent risk factors for morbidity and mortality in patients with congestive heart failure

Keiko Maeda, Takayoshi Tsutamoto, Atsuyuki Wada et al. · Journal of the American College of Cardiology · 2000 · 416 citations

Independent Risk Factors, Heart Failure, Cardiovascular Disease +6

Effect of spironolactone on plasma brain natriuretic peptide and left ventricular remodeling in patients with congestive heart failure

Takayoshi Tsutamoto, Atsuyuki Wada, Keiko Maeda et al. · Journal of the American College of Cardiology · 2001 · 360 citations

Heart Failure, Cardiovascular Disease, Cardiac Mechanic +10

Immediate Administration of Mineralocorticoid Receptor Antagonist Spironolactone Prevents Post-Infarct Left Ventricular Remodeling Associated With Suppression of a Marker of Myocardial Collagen Synthesis in Patients With First Anterior Acute Myocardial Infarction

Masaru Hayashi, Takayoshi Tsutamoto, Atsuyuki Wada et al. · Circulation · 2003 · 318 citations

Ezetimibe Lipid-Lowering Trial on Prevention of Atherosclerotic Cardiovascular Disease in 75 or Older (EWTOPIA 75)

Yasuyoshi Ouchi, Junichi Sasaki, Hidenori Arai et al. · Circulation · 2019 · 208 citations · Full text

Angiotensin II type 1 receptor antagonist decreases plasma levels of tumor necrosis factor alpha, interleukin-6 and soluble adhesion molecules in patients with chronic heart failure

Takayoshi Tsutamoto, Atsuyuki Wada, Keiko Maeda et al. · Journal of the American College of Cardiology · 2000 · 196 citations

Inflammation, Hypertension, Heart Failure +11